295 related articles for article (PubMed ID: 26582878)
1. Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.
Le J; Ny P; Capparelli E; Lane J; Ngu B; Muus R; Romanowski G; Vo T; Bradley J
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e109-16. PubMed ID: 26582878
[TBL] [Abstract][Full Text] [Related]
2. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
3. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
[TBL] [Abstract][Full Text] [Related]
4. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
5. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
Matson KL; Shaffer CL; Beck GL; Simonsen KA
Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
Cies JJ; Shankar V
Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictors of vancomycin-associated nephrotoxicity.
Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ
South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
[TBL] [Abstract][Full Text] [Related]
8. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.
Wei WX; Qin XL; Cheng DH; Lu H; Liu TT
J Clin Pharm Ther; 2016 Dec; 41(6):650-656. PubMed ID: 27578443
[TBL] [Abstract][Full Text] [Related]
10. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors.
Meaney CJ; Hynicka LM; Tsoukleris MG
Pharmacotherapy; 2014 Jul; 34(7):653-61. PubMed ID: 24700598
[TBL] [Abstract][Full Text] [Related]
13. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
Nahata MC
Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity With Vancomycin in the Pediatric Population: A Systematic Review and Meta-Analysis.
Fiorito TM; Luther MK; Dennehy PH; LaPlante KL; Matson KL
Pediatr Infect Dis J; 2018 Jul; 37(7):654-661. PubMed ID: 29280786
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Burgess LD; Drew RH
Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
[TBL] [Abstract][Full Text] [Related]
17. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.
Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T
Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340
[TBL] [Abstract][Full Text] [Related]
18. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.
Bosso JA; Nappi J; Rudisill C; Wellein M; Bookstaver PB; Swindler J; Mauldin PD
Antimicrob Agents Chemother; 2011 Dec; 55(12):5475-9. PubMed ID: 21947388
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer.
Seixas GT; Araujo OR; Silva DC; Arduini RG; Petrilli AS
J Pediatr Hematol Oncol; 2016 Mar; 38(2):e56-62. PubMed ID: 26558810
[TBL] [Abstract][Full Text] [Related]
20. Improved vancomycin dosing in children using area under the curve exposure.
Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
